Pharmaceutical Contract Manufacturing Market Research Report by Type of Contract Manufacturing (API or Bulk Drug Manufacturing and Final Dosage Form), by Service (Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services), by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from USD 95,299.68 Million in 2020 to USD 151,423.31 Million by the end of 2025.
2. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from EUR 83,560.57 Million in 2020 to EUR 132,770.84 Million by the end of 2025.
3. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from GBP 74,285.53 Million in 2020 to GBP 118,033.56 Million by the end of 2025.
4. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from JPY 10,170,891.34 Million in 2020 to JPY 16,160,704.84 Million by the end of 2025.
5. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from AUD 138,387.81 Million in 2020 to AUD 219,886.79 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type of Contract Manufacturing, the Pharmaceutical Contract Manufacturing Market studied across API or Bulk Drug Manufacturing and Final Dosage Form.
Based on Service, the Pharmaceutical Contract Manufacturing Market studied across Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services. The Biologics Manufacturing Services further studied across Biologics API Manufacturing and Biologics FDF Manufacturing. The Pharmaceutical Manufacturing Services further studied across Parenteral/Injectable, Pharmaceutical API Manufacturing, and Pharmaceutical FDF Manufacturing.
Based on End-user, the Pharmaceutical Contract Manufacturing Market studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-size Pharma.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pharmaceutical Contract Manufacturing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Pharmaceutical Contract Manufacturing Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing Market including Abbott, AbbVie, Aenova Group, Almac Group, Amgen, Baxter, Biogen, Biozoc Inc., Boehringer Ingelheim International GmbH, Catalent, Consort Medical, Dr. Reddy's Laboratories, Eli Lilly, Evonik Industries AG, FAMAR Health Care Services, Hospira, Kryptochem Medicament Pvt. Ltd., Labcorp India Pvt. Ltd., Lonza Group, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Pidolma Healthcare, Recipharm AB, Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from USD 95,299.68 Million in 2020 to USD 151,423.31 Million by the end of 2025.
2. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from EUR 83,560.57 Million in 2020 to EUR 132,770.84 Million by the end of 2025.
3. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from GBP 74,285.53 Million in 2020 to GBP 118,033.56 Million by the end of 2025.
4. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from JPY 10,170,891.34 Million in 2020 to JPY 16,160,704.84 Million by the end of 2025.
5. The Global Pharmaceutical Contract Manufacturing Market is expected to grow from AUD 138,387.81 Million in 2020 to AUD 219,886.79 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Pharmaceutical Contract Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Type of Contract Manufacturing, the Pharmaceutical Contract Manufacturing Market studied across API or Bulk Drug Manufacturing and Final Dosage Form.
Based on Service, the Pharmaceutical Contract Manufacturing Market studied across Biologics Manufacturing Services, Drug Development Services, and Pharmaceutical Manufacturing Services. The Biologics Manufacturing Services further studied across Biologics API Manufacturing and Biologics FDF Manufacturing. The Pharmaceutical Manufacturing Services further studied across Parenteral/Injectable, Pharmaceutical API Manufacturing, and Pharmaceutical FDF Manufacturing.
Based on End-user, the Pharmaceutical Contract Manufacturing Market studied across Big Pharma, Generic Pharmaceutical Companies, and Small & Mid-size Pharma.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Pharmaceutical Contract Manufacturing Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Asia-Pacific commanded the largest size in the Pharmaceutical Contract Manufacturing Market in 2020, and it is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Contract Manufacturing Market including Abbott, AbbVie, Aenova Group, Almac Group, Amgen, Baxter, Biogen, Biozoc Inc., Boehringer Ingelheim International GmbH, Catalent, Consort Medical, Dr. Reddy's Laboratories, Eli Lilly, Evonik Industries AG, FAMAR Health Care Services, Hospira, Kryptochem Medicament Pvt. Ltd., Labcorp India Pvt. Ltd., Lonza Group, Mitsubishi Tanabe Pharma, Momenta Pharmaceuticals, Pidolma Healthcare, Recipharm AB, Siegfried Holding AG, Sycon Healthcare, Thermo Fisher Scientific Inc., and Vetter Pharma International GMBH.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Contract Manufacturing Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Pharmaceutical Contract Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Contract Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Contract Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Contract Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Contract Manufacturing Market?
6. What are the modes and strategic moves considered suitable for entering the Global Pharmaceutical Contract Manufacturing Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Service Outlook
3.4. End-user Outlook
3.5. Type of Contract Manufacturing Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biosimilars and generics
5.1.1.2. Increasing investments in drug development and discovery
5.1.1.3. Investments in advanced manufacturing technologies
5.1.2. Restraints
5.1.2.1. Issues with flagship product patents
5.1.3. Opportunities
5.1.3.1. Increasing focus on specialty medicines
5.1.3.2. Attractive nuclear medicine sector
5.1.3.3. growing demand for cell and gene therapies for targeted treatment
5.1.4. Challenges
5.1.4.1. Changing trade policies between countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE OF CONTRACT MANUFACTURING
6.1. Introduction
6.2. API or Bulk Drug Manufacturing
6.3. Final Dosage Form
7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE
7.1. Introduction
7.2. Biologics Manufacturing Services
7.2.1. Biologics API Manufacturing
7.2.2. Biologics FDF Manufacturing
7.3. Drug Development Services
7.4. Pharmaceutical Manufacturing Services
7.4.1. Parenteral/Injectable
7.4.1.1. Capsule
7.4.1.2. Oral Liquid
7.4.1.3. Other Formulations
7.4.1.4. Tablet
7.4.2. Pharmaceutical API Manufacturing
7.4.3. Pharmaceutical FDF Manufacturing
8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END-USER
8.1. Introduction
8.2. Big Pharma
8.3. Generic Pharmaceutical Companies
8.4. Small & Mid-size Pharma
9. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abbott
13.2. AbbVie
13.3. Aenova Group
13.4. Almac Group
13.5. Amgen
13.6. Baxter
13.7. Biogen
13.8. Biozoc Inc.
13.9. Boehringer Ingelheim International GmbH
13.10. Catalent
13.11. Consort Medical
13.12. Dr. Reddy's Laboratories
13.13. Eli Lilly
13.14. Evonik Industries AG
13.15. FAMAR Health Care Services
13.16. Hospira
13.17. Kryptochem Medicament Pvt. Ltd.
13.18. Labcorp India Pvt. Ltd.
13.19. Lonza Group
13.20. Mitsubishi Tanabe Pharma
13.21. Momenta Pharmaceuticals
13.22. Pidolma Healthcare
13.23. Recipharm AB
13.24. Siegfried Holding AG
13.25. Sycon Healthcare
13.26. Thermo Fisher Scientific Inc.
13.27. Vetter Pharma International GMBH
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Service Outlook
3.4. End-user Outlook
3.5. Type of Contract Manufacturing Outlook
3.6. Geography Outlook
3.7. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing demand for biosimilars and generics
5.1.1.2. Increasing investments in drug development and discovery
5.1.1.3. Investments in advanced manufacturing technologies
5.1.2. Restraints
5.1.2.1. Issues with flagship product patents
5.1.3. Opportunities
5.1.3.1. Increasing focus on specialty medicines
5.1.3.2. Attractive nuclear medicine sector
5.1.3.3. growing demand for cell and gene therapies for targeted treatment
5.1.4. Challenges
5.1.4.1. Changing trade policies between countries
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE OF CONTRACT MANUFACTURING
6.1. Introduction
6.2. API or Bulk Drug Manufacturing
6.3. Final Dosage Form
7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY SERVICE
7.1. Introduction
7.2. Biologics Manufacturing Services
7.2.1. Biologics API Manufacturing
7.2.2. Biologics FDF Manufacturing
7.3. Drug Development Services
7.4. Pharmaceutical Manufacturing Services
7.4.1. Parenteral/Injectable
7.4.1.1. Capsule
7.4.1.2. Oral Liquid
7.4.1.3. Other Formulations
7.4.1.4. Tablet
7.4.2. Pharmaceutical API Manufacturing
7.4.3. Pharmaceutical FDF Manufacturing
8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY END-USER
8.1. Introduction
8.2. Big Pharma
8.3. Generic Pharmaceutical Companies
8.4. Small & Mid-size Pharma
9. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. South Korea
10.10. Thailand
11. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. COMPETITIVE LANDSCAPE
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis
12.4. Competitor SWOT Analysis
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. COMPANY USABILITY PROFILES
13.1. Abbott
13.2. AbbVie
13.3. Aenova Group
13.4. Almac Group
13.5. Amgen
13.6. Baxter
13.7. Biogen
13.8. Biozoc Inc.
13.9. Boehringer Ingelheim International GmbH
13.10. Catalent
13.11. Consort Medical
13.12. Dr. Reddy's Laboratories
13.13. Eli Lilly
13.14. Evonik Industries AG
13.15. FAMAR Health Care Services
13.16. Hospira
13.17. Kryptochem Medicament Pvt. Ltd.
13.18. Labcorp India Pvt. Ltd.
13.19. Lonza Group
13.20. Mitsubishi Tanabe Pharma
13.21. Momenta Pharmaceuticals
13.22. Pidolma Healthcare
13.23. Recipharm AB
13.24. Siegfried Holding AG
13.25. Sycon Healthcare
13.26. Thermo Fisher Scientific Inc.
13.27. Vetter Pharma International GMBH
14. APPENDIX
14.1. Discussion Guide
14.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY API OR BULK DRUG MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FINAL DOSAGE FORM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY OTHER FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SCORES
TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RANKING
TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY API OR BULK DRUG MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FINAL DOSAGE FORM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY OTHER FORMULATIONS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 71. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 72. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 73. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 78. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 79. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 80. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 81. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 82. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 83. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 84. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 85. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 86. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 87. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 88. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 89. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 90. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 91. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 92. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 93. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 94. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 95. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 96. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 97. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 98. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 99. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 100. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 101. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 102. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 103. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 104. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 105. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 106. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 107. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 108. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 109. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 110. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: SCORES
TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: BUSINESS STRATEGY
TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PRODUCT SATISFACTION
TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RANKING
TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MERGER & ACQUISITION
TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: INVESTMENT & FUNDING
TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 VS 2025 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2025
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY API OR BULK DRUG MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FINAL DOSAGE FORM, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2025
FIGURE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY OTHER FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2025
FIGURE 37. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: MARKET DYNAMICS
FIGURE 13. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 14. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 VS 2025 (%)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TYPE OF CONTRACT MANUFACTURING, 2025
FIGURE 17. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY API OR BULK DRUG MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY FINAL DOSAGE FORM, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2025 (%)
FIGURE 20. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2020 VS 2025 (USD MILLION)
FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE, 2025
FIGURE 22. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS API MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS FDF MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY DRUG DEVELOPMENT SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL MANUFACTURING SERVICES, 2020 VS 2025 (USD MILLION)
FIGURE 27. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PARENTERAL/INJECTABLE, 2020 VS 2025 (USD MILLION)
FIGURE 28. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULE, 2020 VS 2025 (USD MILLION)
FIGURE 29. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY ORAL LIQUID, 2020 VS 2025 (USD MILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY OTHER FORMULATIONS, 2020 VS 2025 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY TABLET, 2020 VS 2025 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL API MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 33. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL FDF MANUFACTURING, 2020 VS 2025 (USD MILLION)
FIGURE 34. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
FIGURE 35. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2025
FIGURE 37. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY BIG PHARMA, 2020 VS 2025 (USD MILLION)
FIGURE 38. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GENERIC PHARMACEUTICAL COMPANIES, 2020 VS 2025 (USD MILLION)
FIGURE 39. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY SMALL & MID-SIZE PHARMA, 2020 VS 2025 (USD MILLION)
FIGURE 40. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 41. AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 42. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 43. ARGENTINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. BRAZIL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. CANADA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. MEXICO PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. UNITED STATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 49. ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 50. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 51. AUSTRALIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. CHINA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. INDIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. INDONESIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. JAPAN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. MALAYSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. PHILIPPINES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SOUTH KOREA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. THAILAND PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 62. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 63. FRANCE PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 64. GERMANY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 65. ITALY PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 66. NETHERLANDS PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 67. QATAR PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 68. RUSSIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 69. SAUDI ARABIA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 70. SOUTH AFRICA PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 71. SPAIN PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 73. UNITED KINGDOM PHARMACEUTICAL CONTRACT MANUFACTURING MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 74. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 76. GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING MARKET, BY TYPE
